Ellevest, Inc. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ellevest, Inc. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$456
-3.2%
420.0%0.00%
Q4 2022$471420.0%0.00%
Q3 2022$042
+44.8%
0.00%
Q2 2022$0290.0%0.00%
Q1 2022$029
-21.6%
0.00%
Q4 2021$037
+94.7%
0.00%
Q3 2021$019
+111.1%
0.00%
Q2 2021$090.0%0.00%
Q1 2021$090.0%0.00%
Q4 2020$090.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Woodford Investment Management Ltd 11,213,879$254,331,00030.84%
Cormorant Asset Management, LP 1,300,000$29,484,0002.18%
Baupost Group 9,309,168$211,132,0001.85%
SENZAR ASSET MANAGEMENT, LLC 27,397$621,0001.79%
ARMISTICE CAPITAL, LLC 1,180,000$26,762,0001.75%
Old West Investment Management, LLC 111,101$2,519,0001.27%
Chescapmanager LLC 403,321$9,147,0001.06%
Virtus ETF Advisers LLC 30,055$682,0000.60%
Rock Springs Capital Management LP 652,600$14,801,0000.57%
Foundation Asset Management, LP 27,154$616,0000.53%
View complete list of THERAVANCE BIOPHARMA INC shareholders